Morgan Mace
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma Research and Treatments
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 5
-
- Chronic Myeloid Leukemia Treatments 3
- Acute Myeloid Leukemia Research 2
- Co-authors
- Elias Jabbour (4 shared papers)Hagop M. Kantarjian (3 shared papers)Naveen Pemmaraju (2 shared papers)Kayleigh Marx (2 shared papers)Naval Daver (2 shared papers)Courtney D. DiNardo (2 shared papers)Jörge E. Cortes (2 shared papers)Nitin Jain (2 shared papers)
- Journals
- Blood (1 paper)American Journal of Hematology (1 paper)American Journal of Health-System Pharmacy (1 paper)Therapeutic Drug Monitoring (1 paper)Drugs of today (1 paper)
- Partner nations
- United StatesFrance
In The Last Decade
Morgan Mace
8 papers receiving 349 citations
Peers
Comparison fields: 5 of 38
- Hematology 244
- Genetics 76
- Dermatology 42
- Oncology 84
- Virology 14
Countries citing papers authored by Morgan Mace
This map shows the geographic impact of Morgan Mace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morgan Mace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morgan Mace more than expected).
Fields of papers citing papers by Morgan Mace
This network shows the impact of papers produced by Morgan Mace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morgan Mace. The network helps show where Morgan Mace may publish in the future.
Co-authors
The 25 scholars most cited alongside Morgan Mace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 293 | |
| 2 | 2001 | 19 | |
| 3 | 2016 | 17 | |
| 4 | 2015 | 12 | |
| 5 | 2017 | 3 | |
| 6 | 2015 | 3 | |
| 7 | Utilization of methylnaltrexone (relistor) for opioid-induced constipation in an oncology hospital. | 2011 | 3 |
| 8 | 2024 | 1 |
About Morgan Mace
Morgan Mace is a scholar working on Genetics, Hematology, Oncology, Infectious Diseases and Surgery, having authored 8 papers that have together received 351 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Acute Myeloid Leukemia Research (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), HIV Research and Treatment (1 paper), Gastrointestinal motility and disorders (1 paper), HIV/AIDS Research and Interventions (1 paper) and Anesthesia and Pain Management (1 paper). The work is most often cited by research in Hematology (244 citations), Genetics (76 citations), Dermatology (42 citations), Oncology (84 citations) and Virology (14 citations). Morgan Mace has collaborated with scholars based in United States and France. Frequent co-authors include Elias Jabbour, Hagop M. Kantarjian, Naveen Pemmaraju, Kayleigh Marx, Naval Daver, Courtney D. DiNardo, Jörge E. Cortes, Nitin Jain, Wendy Covert and Christopher B. Benton. Their work appears in journals such as Blood, American Journal of Hematology, American Journal of Health-System Pharmacy, Therapeutic Drug Monitoring and Drugs of today.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.